Home
Categories
EXPLORE
True Crime
Comedy
Society & Culture
Business
News
Sports
TV & Film
About Us
Contact Us
Copyright
© 2024 PodJoint
Podjoint Logo
US
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts122/v4/cd/88/e6/cd88e633-c6e5-7f68-73fd-5bc0ff74f4f4/mza_14097111363740875412.jpg/600x600bb.jpg
ValSource Viewpoints
ValSource
27 episodes
1 day ago
Tune in to our podcast as ValSource experts explore the latest developments and insights within pharmaceutical, advanced therapy medicinal products, biologics and medical device regulated industries.
Show more...
Science
RSS
All content for ValSource Viewpoints is the property of ValSource and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Tune in to our podcast as ValSource experts explore the latest developments and insights within pharmaceutical, advanced therapy medicinal products, biologics and medical device regulated industries.
Show more...
Science
https://d3t3ozftmdmh3i.cloudfront.net/production/podcast_uploaded_nologo/29889456/29889456-1662575762338-c90678c392fbd.jpg
Building an Effective and Engaged Safety Culture in the Construction Industry
ValSource Viewpoints
17 minutes 14 seconds
1 year ago
Building an Effective and Engaged Safety Culture in the Construction Industry

This episode is the first of a new safety-focused series.

ValSource Senior Safety Consultant Art Limper, known for his career enhancing safety protocols and promoting best practices across all aspects of pharmaceutical manufacturing and operations, discusses what it takes to create a successful safety program. Art has been a key contributor to ValSource Safety Solutions, a comprehensive program combining ValSource consulting services and resources with PIMSHQ’s innovative PIMS Safety software. 

 

ValSource Viewpoints
Tune in to our podcast as ValSource experts explore the latest developments and insights within pharmaceutical, advanced therapy medicinal products, biologics and medical device regulated industries.